Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
84.80
+1.12 (1.34%)
After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Cap
48,18352,08746,20649,50545,16145,98042,48843,57438,92155,63457,56545,83442,01857,34350,13445,38551,18158,93773,15180,852
Market Cap Growth (YoY)
2.67%13.28%8.75%13.61%16.03%-17.35%-26.19%-4.93%-7.37%-2.98%14.82%0.99%-17.90%-2.70%-31.46%-43.87%-27.57%-8.67%40.66%41.96%
Enterprise Value
45,19452,08743,23845,98442,01942,68139,35240,36335,24754,40556,63544,95640,91556,58949,65244,86150,12958,10472,34480,076
Last Close Price
83.6890.4680.0885.2577.7778.2172.4874.0365.9992.3795.5676.2569.2894.3382.7374.6182.6395.09117.72129.55

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
49.9351.9942.6046.5833.5211.2510.3510.629.5238.0141.1933.1529.6141.7434.3330.5835.6241.1648.2554.43
Forward PE
26.6329.5227.0430.9330.1631.6129.5831.1926.7832.3734.6828.4125.8636.1032.9130.3531.3636.1546.0852.98
PEG Ratio
2.192.452.093.243.204.215.143.692.863.124.342.772.224.484.302.952.552.703.163.38
PS Ratio
7.408.007.338.167.688.097.698.017.3210.6811.219.157.8610.589.1110.179.5411.0113.6615.45
PB Ratio
4.68-4.474.794.434.364.194.364.087.488.096.896.318.998.397.828.239.9212.5213.85
P/TBV Ratio
--6.396.676.246.055.946.215.659.5110.659.068.5712.3911.9710.5510.7713.3717.0118.85
P/FCF Ratio
44.22-42.4137.0856.1678.2167.11150.3175.5097.30212.1171.3051.9881.6649.8646.6249.0546.6051.0757.49
P/OCF Ratio
35.47-34.0131.0344.4157.8448.4980.3548.2764.24108.9851.1740.3260.9840.4637.2639.1038.5042.4146.68

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
6.948.006.867.587.147.517.137.426.6310.4411.038.977.6510.449.0310.059.3510.8513.5015.30
EV/EBITDA Ratio
31.1935.9528.6732.3626.5626.3324.9426.3122.5634.4438.4430.9225.4334.4227.0127.3927.6632.3138.4343.87
EV/EBIT Ratio
31.1935.9532.1036.3729.4729.0527.6229.2824.9538.0942.7434.3527.9237.6729.2429.9429.9334.9441.4447.37
EV/FCF Ratio
41.48-39.6934.4452.2572.6062.16139.2368.3895.15208.6869.9450.6180.5949.3846.0848.0445.9450.5156.94

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
--0.070.070.070.060.070.070.070.090.090.100.100.100.110.110.110.110.110.11
Debt / EBITDA Ratio
--1.363.642.021.561.621.971.841.711.801.791.722.291.621.431.571.381.451.69
Debt / FCF Ratio
---2.001.362.923.12-2.362.42-14.181.94-2.723.232.752.363.122.43
Net Debt / Equity Ratio
---0.29-0.34-0.31-0.32-0.32-0.33-0.39-0.17-0.14-0.14-0.18-0.13-0.09-0.09-0.17-0.14-0.14-0.13
Net Debt / EBITDA Ratio
---5.72-18.17-9.07-7.48-7.42-9.22-9.71-3.19-2.58-2.47-2.91-2.75-1.34-1.08-2.40-1.69-1.71-1.91
Net Debt / FCF Ratio
--140.69-9.96-6.09-13.95-14.2618.48-12.47-4.538.40-19.62-3.2957.68-2.24-2.45-4.21-2.88-3.66-2.74
Asset Turnover
0.260.260.130.120.120.130.120.120.120.140.140.140.140.150.170.160.160.170.170.17
Inventory Turnover
2.560.690.320.310.310.320.260.290.250.270.270.280.280.300.400.320.340.360.400.40
Quick Ratio
--3.302.832.983.533.333.122.702.322.322.062.151.961.821.872.612.262.302.07
Current Ratio
--4.423.724.004.684.454.183.463.713.753.383.283.153.013.033.833.373.413.08
Return on Equity (ROE)
4.55%4.55%3.71%0.63%2.95%3.71%4.18%4.13%4.43%5.22%4.90%5.32%5.17%4.10%5.72%6.84%5.84%7.34%7.11%6.44%
Return on Assets (ROA)
3.53%3.53%3.01%0.80%1.96%2.93%2.91%2.47%2.82%3.64%3.32%3.56%3.51%2.79%3.89%4.63%4.04%5.00%4.81%4.24%
Return on Invested Capital (ROIC)
--5.59%1.55%3.60%4.85%4.82%4.39%5.22%5.61%5.11%5.56%5.66%4.38%6.16%7.43%6.60%7.92%7.45%7.03%
Return on Capital Employed (ROCE)
8.49%8.49%4.06%1.29%2.70%3.92%3.90%3.17%3.66%4.38%4.31%4.49%4.62%3.44%5.17%6.08%5.40%6.46%6.32%5.42%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
2.09%1.92%2.35%2.15%2.98%8.89%9.66%9.42%10.50%2.63%2.43%3.02%3.38%2.40%2.91%3.27%2.81%2.43%2.07%1.84%
FCF Yield
2.26%0.00%2.36%2.70%1.78%1.28%1.49%0.67%1.32%1.03%0.47%1.40%1.92%1.22%2.01%2.15%2.04%2.15%1.96%1.74%
Buyback Yield / Dilution
1.64%1.75%1.21%1.47%2.07%2.71%2.70%2.70%1.87%0.98%1.11%1.51%2.40%2.62%2.94%2.50%1.14%0.51%0.30%0.00%
Total Shareholder Return
1.64%1.75%1.21%1.47%2.07%2.71%2.70%2.70%1.87%0.98%1.11%1.51%2.40%2.62%2.94%2.50%1.14%0.51%0.30%0.00%
SEC Filings: 10-K · 10-Q